Proliferative diabetic retinopathy treated with intravitreal ranibizumab and photocoagulation directed at ischemic retinal areas —A randomized study
ConclusionsPIR + IVR or PRP + IVR are comparable strategies regarding FLA control in PDR and led to similar retinal function impairment, based on ERG changes up to one-year follow-up.Trial registration numberNCT03904056, date of registration 02/11/2019, retrospectively registered.
Source: Documenta Ophthalmologica - Category: Opthalmology Source Type: research
More News: Diabetes | Endocrinology | Eyes | Lucentis | Opthalmology | Ranibizumab Injection | Study | Vitamin A